Phathom Pharmaceuticals
PHAT
PHAT
171 hedge funds and large institutions have $1.03B invested in Phathom Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 49 increasing their positions, 50 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
28% more funds holding
Funds holding: 134 → 171 (+37)
0.8% less ownership
Funds ownership: 87.88% → 87.07% (-0.8%)
2% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 50
Holders
171
Holding in Top 10
8
Calls
$17.8M
Puts
$1.18M
Top Buyers
| 1 | +$9.46M | |
| 2 | +$5.64M | |
| 3 | +$5.62M | |
| 4 |
Jane Street
New York
|
+$3.96M |
| 5 |
CP
Catalys Pacific
Tokyo,
Japan
|
+$3.74M |
Top Sellers
| 1 | -$42.8M | |
| 2 | -$6.13M | |
| 3 | -$5.27M | |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$5.05M |
| 5 |
Walleye Capital
New York
|
-$3.42M |
